Orexo (OX-MPI Project) Overview

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • Asset Purch.

  • Financing Rounds
  • 1

Orexo (OX-MPI Project) General Information

Description

A pharmaceutical project in Uppsala, Sweden. The project deals with highly selective anti-inflammatory compound targeting microsomal prostaglandin E synthase (mPGES-1).

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Corporate Office
  • P.O. Box 303
  • 751 05 Uppsala
  • Sweden
Primary Industry
Buildings and Property
Other Industries
Drug Discovery
Pharmaceuticals
Acquirer
Vertical(s)
Corporate Office
  • P.O. Box 303
  • 751 05 Uppsala
  • Sweden

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Orexo (OX-MPI Project) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Orexo (OX-MPI Project)‘s full profile, request access.

Request a free trial

Orexo (OX-MPI Project) Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Orexo (OX-MPI Project)‘s full profile, request access.

Request a free trial

Orexo (OX-MPI Project) FAQs

  • Where is Orexo (OX-MPI Project) headquartered?

    Orexo (OX-MPI Project) is headquartered in Uppsala, Sweden.

  • What industry is Orexo (OX-MPI Project) in?

    Orexo (OX-MPI Project)’s primary industry is Buildings and Property.

  • Is Orexo (OX-MPI Project) a private or public company?

    Orexo (OX-MPI Project) is a Private company.

  • What is Orexo (OX-MPI Project)’s current revenue?

    The current revenue for Orexo (OX-MPI Project) is .

  • Who are Orexo (OX-MPI Project)’s investors?

    Orexo has invested in Orexo (OX-MPI Project).

  • When was Orexo (OX-MPI Project) acquired?

    Orexo (OX-MPI Project) was acquired on 29-Sep-2017.

  • Who acquired Orexo (OX-MPI Project)?

    Orexo (OX-MPI Project) was acquired by Gesynta Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process